Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans
Clinical Sarcoma Research · 2012-12 · 2 (1)
DOI: 10.1186/2045-3329-2-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Sarcoma Research, online erschienen am 27.01.2012. Verfasst von Emanuela Palmerini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, Bologna, 40136, Italy. emanuela.palmerini@ior.it. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).
Abstract (Originalsprache)
BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a relatively common soft-tissue tumor. A more aggressive appearing fibrosarcoma may arise in DFSP, changing its biological behavior. CD34 and apolipoprotein-D are highly expressed in DFSP, but their prognostic significance is uncertain. METHODS: DFSP and fibrosarcomatous-DFSP (FS-DFSP) patients referred to our institute between 1982 and 2009 were identified. Fibrosarcomatous changes, expression of CD34 and apolipoprotein-D were evaluated. RESULTS: 40 patients, (median age 43 years, 55% males) were identified. Tumor was located in the limbs in 60%, in the trunk in 40%. Thirty-seven patients had localized and 3 had metastatic disease. Thirteen (32%) patients were FS-DFSP. All but one underwent surgery with adequate surgical margins in 72%. 7 FS-DFSP received also radiotherapy (RT). Chemotherapy was administered to 3 patients with FS-DFSP. With a median follow-up of 49 months, the 5-OS was 90%. Local recurrence rate was 23%: 42% FS-DFSP, 15% DFSP. Metastases developed in three FS-DFSP patients. The 5-year EFS was 70% in localized patients. Histology (DFSP 75% vs. FS-DFSP 52%, p = 0.002), surgical margins (adequate 74% vs. inadequate 55%, p = 0.02), site (limb 47% vs. trunk 100%), CD34 expression (CD34 positive: 70% vs. CD34 negative: 33%, p = 0.05), and apolipoprotein-D expression (Apo-D positive: 73% vs. Apo-D negative: 33%, p = 0.02) influenced the 5-year EFS, whereas sex, use of RT or number of previous surgical treatments did not. CONCLUSIONS: Patients with DFSP have a high survival probability. Site, adequate surgical margins, presence of the fibrosarcomatous component, lack of CD34 expression and apolipoprotein-D influence outcome.
Autor:innen und Institutionen
- Chemotherapy, Musculoskeletal Oncology Department, Istituto Ortopedico Rizzoli, via Pupilli 1, Bologna, 40136, Italy. emanuela.palmerini@ior.it.
Zitieren
APA
Palmerini, E., Gambarotti, M., Staals, E. L., Zanella, L., Sieberova, G., Longhi, A., Cesari, M., Bonarelli, S., Picci, P., Ruggieri, P., Alberghini, M., & Ferrari, S. (2012). Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. Clinical Sarcoma Research, 2(1). https://doi.org/10.1186/2045-3329-2-4
Vancouver
Palmerini E, Gambarotti M, Staals EL, Zanella L, Sieberova G, Longhi A, et al. Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. Clinical Sarcoma Research. 2012;2(1). doi:10.1186/2045-3329-2-4
BibTeX
@article{Palmerini2012,
author = {Palmerini, Emanuela and Gambarotti, Marco and Staals, Eric L and Zanella, Licciana and Sieberova, Gabriela and Longhi, Alessandra and Cesari, Marilena and Bonarelli, Stefano and Picci, Piero and Ruggieri, Pietro and Alberghini, Marco and Ferrari, Stefano},
title = {Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans},
journal = {Clinical Sarcoma Research},
year = {2012},
volume = {2},
number = {1},
doi = {10.1186/2045-3329-2-4}
}
EUVIMED